Published in Lab Business Week, July 29th, 2007
A poster entitled "Bio-adhesive Vaginal Foam: In-Vitro and In-Vivo Adhesion Profile" will be presented by Foamix's CTO, Dr. Doron Friedman, at the 34th Annual Meeting of the Controlled Release Society (CRS) in Long Beach, California, US July 7-11, 2007. The abstract will also be published in CRS Journal.
Foamix accomplished its objective to be the first to develop a new type of vaginal foam vehicle. While topical formulations, such as creams, lotions, gels and ovules, are commonly used for delivery to the vaginal cavity,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.